Israel Englander Renovo Rx, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 82,353 shares of RNXT stock, worth $112,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,353
Previous 86,316
4.59%
Holding current value
$112,823
Previous $97,000
10.31%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNXT
# of Institutions
16Shares Held
2.87MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1.34 Million0.27% of portfolio
-
Bank Of Montreal Toronto, A6975KShares$1.34 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX315KShares$431,8130.05% of portfolio
-
Geode Capital Management, LLC Boston, MA233KShares$319,1230.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$133,1160.01% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $12.4M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...